Sleep fragmentation increases as Alzheimer's disease (AD) progresses. Its effects on cognition, specifically vigilant attention, are profoundly important because vigilant attention is thought to be the first step in memory acquisition. To our knowledge, no one has experimentally studied the effect of sleep fragmentation on vigilant attention in persons with AD. Therefore, this study piloted an experimental method using sound (tones produced by an audiometer) to induce sleep fragmentation. Participants enrolled in the University of Arkansas for Medical Sciences Memory Research Center ([MRC] n ¼ 4) underwent one night of undisturbed and one of fragmented sleep. All participants tolerated the earphone needed for the tone-induced sleep fragmentation (TISF) method, and we were able to score awakenings in real time. However, only 50% of tones produced awakenings. The findings suggest that this experimental method is feasible for use in persons with mild AD. Based on the results, we will increase the duration, intensity, and frequency of tones delivered for optimal result.
The incidence of Alzheimer's disease (AD) will increase to almost 1 million new cases annually by 2050 (Hebert, Beckett, Scherr, & Evans, 2001) . Although prevention and cure for AD are important goals, interventions are needed now for persons with AD and their caregivers to sustain their quality of life. In particular, stabilizing or slowing the progression of cognitive decline in those with AD could help maintain independence and delay admission to long-term care facilities. Therefore, we need to identify modifiable factors that could lead to interventions to slow cognitive decline. One potentially modifiable factor, and a prominent clinical feature of AD that may influence cognitive decline, is sleep fragmentation.
Nighttime sleep fragmentation and excessive daytime sleepiness often occur together. Unlike persons with sleep deprivation (characterized by sleep deficit), persons with sleep fragmentation may have adequate time dedicated to sleep but experience frequent brief awakenings throughout the night. They may not be aware of these frequent brief awakenings, but they do know that their sleep is not refreshing and they experience excessive daytime sleepiness. In many cases, sleep fragmentation and daytime sleepiness increase as AD progresses in severity (Bliwise, Hughes, McMahon, & Kutner, 1995) .
Sleep fragmentation and daytime sleepiness have significant adverse effects on vigilant attention in persons without AD (Bonnet, 1989; Edell-Gustafsson & Hetta, 2001; Kingshott, Cosway, Deary, & Douglas, 2000) . Because vigilant attention is thought to be the first step in memory acquisition (Rizzo, Anderson, Dawson, Myers, & Ball, 2000) , the question as to whether sleep fragmentation may also have adverse effects on vigilant attention in persons with AD is a potentially important one. However, the evidence pertaining to this question is not conclusive. Research on persons with AD has sometimes not measured sleep objectively or controlled for important covariates. Further, we cannot assume that sleep fragmentation has the same effects on vigilant attention in persons with and without AD because the neuronal degeneration that characterizes AD may cause alterations in sleepÀwake mechanisms (Everitt & Robbins, 1997; Szymusiak, 1995) . Thus, we do not know whether sleep fragmentation has additive adverse effects on vigilant attention in AD or whether fragmentation of particular sleep stages affects vigilant attention. Clarification of these issues will help determine whether interventions to improve sleep might stabilize or improve vigilant attention in persons with AD.
This pilot study tested the feasibility of using an experimental method to measure the effect of sleep fragmentation on vigilant attention in persons with AD. Specifically, the study used sound (tones sounded with an audiometer) to induce sleep fragmentation. Research questions were as follows:(a) Will persons with AD tolerate the earphone needed for the tone-induced sleep fragmentation (TISF) method? (b) Can a sleep technologist recognize electroencephalogram (EEG) awakenings and arousals after tones in real time? (c) What percentage of tones produce an awakening according to EEG?
Material and Method Study Design and Setting
We used a repeated measures design with one undisturbed and one fragmented night of sleep ( Figure 1 ). The study was conducted in the University of Arkansas for Medical Sciences (UAMS) General Clinical Research Center (GCRC), which provided control of extraneous variables such as noise, visitors, and electrical interference that might introduce error in measurement or interpretation of the results. The Institutional Review Board and the Veterans Administration Research and Development Committee approved the study. The first author (C.S.C.) obtained informed consent from participants (or a legally authorized representative if it was determined that the person with AD was unable to provide informed consent) at each stage of the study. Because of the possibility of temporary daytime sleepiness and cognitive status changes, a friend or family member was required to accompany the participants throughout the study and drive them back home.
Participants
We recruited a final sample of five participants, an adequate sample to provide descriptive data on the TISF method. Criteria for inclusion in this study were enrollment in the UAMS Memory Research Center (MRC) database and a consensus diagnosis of mild AD (clinical dementia rating [CDR] ¼ 1; Morris, 1997) . A consensus diagnosis is determined after extensive cognitive testing. A consensus committee consisting of behavioral neurologists, geriatrician, neurophysiologists, and nurses make the diagnosis according to criteria contained in the Diagnostic and Statistical Manual of Mental Disorders, revised fourth edition (American Psychiatric Association, 1994) and the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria (McKhann et al., 1984) . A CDR of 1 indicates that the person with AD has moderate memory loss and may have difficulty with time relationships and handling problems. In addition, they may be unable to function independently and have mild but definite impairment of function at home. Participants also had to have a Mini Mental State Exam (MMSE) score >15, fewer than 10 respiratory sleep disturbances per hour during the first night of polysomnography (PSG), fewer than 5 leg movement sleep disturbances (periodic limb movement index with awakenings <5) on the first night of PSG; self-report of regular bedtime and wake time schedule (within 30 min), with at least 8 hr in bed for the 5 days prior to the study, adequate hearing, and an available family member or friend to stay with the participant in the GCRC as well as be on a consistent dose of a cholinesterase inhibitor or N-methyl-D-aspartic acid for the 7 days prior to the study or not receiving these drugs.
Potential participants were excluded if there was self-or family report of acute medical or psychological illness. Such illnesses could cause delirium, active hallucinations, or delusions, and the TISF method could exacerbate these problems. C.S.C., an advanced practice nurse, screened the participants' hearing with a Maico MA 27 pure-tone audiometer (American Speech-Language Hearing Association, 1997). Participants whose hearing was not adequate, according to guidelines provided by the study audiologist, were excluded from the remainder of the study. Patients taking benzodiazepines or other hypnotics were also excluded because these drugs could raise the threshold for awakening.
Description of Undisturbed Sleep and TISF Method
Undisturbed Sleep. We individualized bedtime and wake time according to the participant's usual hours of sleep, which were determined from a sleep diary that the caregiver kept for 5 days and nights prior to PSG. On Night 1, a registered polysomnographic technologist (RPSGT) conducted overnight PSG to acclimate participants to the procedure and screen for sleep disorders such as obstructive sleep apnea (OSA) and periodic limb movement disorder. An insert earphone was positioned prior to sleep to accustom the participant to it. Otherwise, the RPSGT allowed the participants to sleep undisturbed. The RPSGT used standard calibration and recording procedures as described in (Rechtschaffen & Kales, 1968) . At the time these data were collected, the American Academy of Sleep Medicine had not yet published the AASM Manual for the Scoring of Sleep and Associated Events (American Academy of Sleep Medicine, 2007), which was designed to replace the Rechtschaffen and Kales ([R&K] 1968) standard of sleep staging and unify it with scoring roles for the most important events associated with sleep (Lemmer & Lemmer, 2005) , Therefore, we used the R&K criteria with exceptions proposed by Bliwise, a leading expert in sleep in persons with dementia (Bliwise, Willians, Irbe, Ansari, & Rye, 2000) . Although rescoring the sleep studies with the new criteria might have resulted in changed results, few reliability studies have been carried out with the new criteria. Finally, because an important aspect of this feasibility study involved the ability to score sleep studies in real time to enable administration of the TISF method, we determined that rescoring the sleep studies with the new criteria would not help us address the real-time feasibility issue.
We used a Grass Portable Polysomnography Data Acquisition System (Astro-Med, Inc., West Warwick, RI) to measure sleep. The portable PSG system displays electrographically the EEG, electrooculogram (EOG), electromyogram (EMG), electrocardiogram (ECG), airflow, leg movement, respiratory excursion, and arterial oxygen saturation. EEG electrodes were placed at C3, C4, O1, and O2 sites and referred to the contralateral mastoid (A2, A1). Supplementary channels included nasal and oral thermistors to measure airflow, bilateral anterior tibialis myogram to measure leg movement, elastic bands on the chest and abdomen to measure respiratory excursion, and a finger probe to measure oxygen saturation. The placement of EEG electrodes was performed in accordance with the international 10/20 system of electrode placement (Jasper, 1958) . Cleansing and application was performed in accordance with procedures outlined in Sleep Disorders Medicine, 2nd edition (Keenan, 1999) . Each electrode site was cleansed and lightly abraded with a gel-based abrasive substance. Scalp electrodes were firmly attached with collodium. When the collodium was dry, electrolyte gel was injected into the gold electrode cup using a blunt needle syringe. Electrode impedances were measured with an impedance meter and were below 5,000 Ohms. Finally, biological calibrations were performed to ensure accurate detection of electrical signals.
All sleep studies were scored by the RPSGT, scoring sleep stages using standardized scoring rules (American Academy of Sleep Medicine, 1999; American Sleep Disorders Association, 1992) with two exceptions: (a) all nonÀrapid eye movement (NREM) stages collapsed into ''indeterminate NREM sleep'' because people with cognitive impairment have diffuse delta and theta activities; and (b) for people without rapid eye movement (REM) atonia, conventional scoring criteria for REM atonia were disregarded (Bliwise et al., 2000) . The RPSGT received training on scoring of sleep in cognitively impaired elders from Bliwise. Interscorer reliability of our RPSGT and Bliwise prior to beginning of the study and quarterly during data collection ranged from .85 to .95. TISF Method. On Night 2, we individualized bedtime and wake time as we did on Night 1. The RPSGT conducted overnight PSG using the standardized method described previously.
After we scored 10 min of sleep from the PSG tracing, C.S.C. delivered tones with a Maico MA 27 pure-tone air conduction audiometer beginning at 5 decibels ([dB] warble function) to induce an EEG-scored awakening according to the exceptions outlined above. The RPSGT judged whether an awakening occurred. If there was no awakening, C.S.C. increased the volume of the tone to 1,000 Hz by 5-dB intervals every 5 s until the participant awakened. When we scored an awakening, the tone delivery stopped until the participant slept another 10 min, then the tone delivery resumed.
If the 85-dB ceiling is reached without an EEG-scored awakening, then C.S.C. entered the participant's room and called out the participant's name. If the participant gave no response, then C.S.C. gently touched the participant's arm. We noted a behavioral awakening when the participant gave an appropriate verbal response.
Rationale for TISF method (frequency/timing/volume). Awakenings were defined as a return to alpha and/or low voltage, mixed frequency activity rhythm lasting over half of one 30-s epoch (Rechtschaffen & Kales, 1968) . Although in healthy persons, ''arousals are scored in REM sleep only when accompanied by concurrent increases in submental EMG amplitude,'' we scored awakenings based on return to alpha in our AD population (Bliwise et al., 2000, p. 275 ). Because we observed as few as 0À1 awakenings a night and as many as 16 awakenings in 30 min in persons with AD, we reviewed the literature for other studies using the TISF method to determine the most appropriate way to implement this method with our population. Other investigators have produced arousals as frequently as every 3À5 min to mimic the patterns of arousal seen in OSA syndrome (Martin, Brander, Deary, & Douglas, 1999; Martin, Engleman, Kingshott, & Douglas, 1997; Martin, Wraith, Deary, & Douglas, 1997) . We chose tone delivery after 10 min of sleep because it was less intrusive than the frequency used by Martin and his group but still sufficiently frequent to clearly interrupt sleep and produce a measurable effect.
We chose a mid-range tone (1,000 Hz) audible to the majority of older adults (age-associated hearing loss is usually limited to higher range tones (American Speech-Language Hearing Association, 1997). The initial volume was set at 5 dB for 1 s. When the ceiling of 85 dB was reached, a behavioral awakening was recorded. The ceiling of 85 dB for 1 s is recognized as safe by the American Academy of Audiology (2003).
Variables
We collected demographic data and a brief sleep history and evaluated baseline sleep with a self-report sleep log and nighttime PSG (Night 1 in the GCRC). We then answered our feasibility questions with a log of descriptive information collected during the sleep studies.
Sleep. In addition to the nighttime sleep log, we used PSG to collect minutes of total sleep time (TST), percentage of night slept, minutes and percentage of time awake, minutes of NREM sleep, minutes of REM sleep, minutes to fall asleep (sleep latency), and frequency of awakenings. When analyzing the PSG data, initial scoring assigned a sleep stage (NREM sleep or stages 1, 2, 3, 4 REM sleep) to each epoch (30-s segment of recording). After we scored each epoch for the entire recording, we calculated the total minutes of wake time and sleep time and thus were able to describe sleep by stage. We totaled awakenings and described them based on their cause (spontaneous, periodic limb movements of sleep, apneas, hypopneas, bathroom, tones, and behavioral) and also totaled the number of awakenings per hour of sleep.
Feasibility of the TISF method. C.S.C. and the technologist checked the participant's ability to keep the earphone in place throughout the night. We also maintained a log of audiometer use that included the timing and loudness of tones required to wake participants and their responses. We compared the number of tones sounded to the number of awakenings in real time. We then compared these notes to our review of PSG data to assess scoring accuracy.
Demographic data. C.S.C. used a standard form to collect data on age, diagnoses, medications, and descriptors of the sample. Scheduled medications were classified as (a) cholinesterase inhibitors or N-methyl-D-aspartic acid, (b) sedating antidepressants, (c) antipsychotics, (d) novel antipsychotics, or (e) analgesics. We requested that the dosage of scheduled medications remain the same during the study unless a change was medically necessary, and we monitored and recorded any changes.
Results
The goal of this study was to establish the feasibility of the procedures, identify problem areas that needed modification, and provide preliminary estimates of standard deviations and correlation coefficients in longitudinal measurements.
Of the 9 potential participants who were recruited, 4 were enrolled in the study. Of the 5 who were not enrolled, 2 were poor sleepers according to their sleep history, 1 had a cerebral hemorrhage before admission to the GCRC, and 1 withdrew her consent after she learned that she could not smoke in the GCRC. The final 1 of these 5 had an apnea/hypopnea index >10 during the first night of PSG and was not able to complete 2 nights of PSG. The 4 remaining participants did complete 2 nights of PSG.
The final sample included 1 female and 3 males. Their average age was 67.5 years (SD 11.03), with a range from 51 to 74. All were Caucasian and had at least a high school education. Two participants had partially completed college and one had a graduate degree in education. Their mean MMSE score was 24.4 (SD 3.64), with a range of 20-29, indicating mildly impaired cognitive status. All participants had a consensus diagnosis of mild AD (CDR ¼ 1).
Measures of sleep continuity calculated from the undisturbed sleep night showed a mean sleep efficiency (ratio of time in bed to time asleep) of 66.2% (SD 13.01), with a range from 45% to 80.0% (Table 1) . Healthy adults have an average sleep efficiency of about 95%. TST ranged from 242.5 to 369.0 min, with a mean of 333.88 min (SD 61.20) . Although all participants reported about 8 hr of sleep per night for 5 days prior to the study, during the study they only slept on an average of 5.29 hr per night. On the first undisturbed night of sleep, participants awakened an average of 31 times. We found that, on average, 18.4 awakenings were spontaneous and 9.2 awakenings were due to respiratory events.
Paired-sample t tests were conducted to evaluate whether there were significant differences between the undisturbed night of sleep and the TISF night. The number of sleep stage shifts during the undisturbed night of sleep (M ¼ 72.00, SD ¼ 24.34) tended to be less than that on the TISF night (M ¼ 102.75, SD ¼ 18.75), t(3) ¼ À2.51, p ¼ .08. Total awakenings, shown in Table 2 , also tended to differ between the undisturbed night of sleep (M ¼ 29.5, SD ¼ 10.85) and the TISF night All four participants tolerated the earphone, and we were able to score awakenings and EEG arousals in real time and identify all NREM sleep stages (Figure 2 ). About 50% of the tones resulted in an EEG scored awakening. All tones that resulted in awakenings were at the maximum 85-dB level. Bonnet (1989) developed the TISF method in an attempt to separate the confounded measurement of hypoxemia and sleep fragmentation in persons with OSA. When Bonnet was able to separate the effects of hypoxemia and sleep fragmentation (n ¼ 11), he found that fragmented sleep had an additive adverse effect on vigilant attention. Findings by Martin and his group (Martin, Engleman, Deary, & Douglas, 1996) affirmed Bonnet's work. They found that one night of sleep fragmentation (without hypoxemia) made normal subjects sleepier during the day, impaired their subjectively assessed mood, and decreased their mental flexibility and vigilant attention. We sought to determine whether Bonnet's method was feasible for use in persons with AD. 
Discussion

Recommendations for Future TISF Use
Because we found that sleep was severely disturbed by spontaneous awakenings on Night 1, we will add one night for acclimatization to the sleep laboratory to account for the first-night effect. When people sleep in unfamiliar surroundings, such as a sleep laboratory, their sleep patterns may not be typical during the first night of change but may revert to patterns that are more usual on subsequent nights. Because of the first-night effect, participants had a shortened TST and were essentially sleep deprived during their two nights in the GCRC, which may have confounded the TSIF method. In future studies, we will control for lights out and rise time (10 p.m.-7 a.m. for all participants) to ensure an adequate time in bed and minimize the effects of sleep deprivation.
Finally, because we found that sleep was disturbed due to respiratory events, though participants described themselves as good sleepers, we will use the Epworth Sleepiness Scale and actigraphy instead of a subjective report of sleep to establish baseline sleep patterns. The Epworth Sleepiness Scale describes daytime sleepiness, which may help identify those with disturbed nighttime sleep. This simple questionnaire asks the respondent to rate the chance, using a Likert scale, that she or he would doze off or fall asleep in eight situations commonly encountered in daily life. The total Epworth Sleepiness Scale scores have significantly distinguished normal participants from participants in various diagnostic groups including those with OSA (Johns, 1991) .
An actigraph is a small device that can be worn like a wristwatch for up to 3 weeks. The actigraph contains a pizoelectric cell that records participant movements, which are averaged over a predetermined period of time, or epoch. The recordings can be downloaded to a computer where numerous parameters describing sleep/wake continuity can be calculated from an algorithm. The actigraph can thus provide objective proxy measures for TST, total wake time, sleep efficiency, and other sleep continuity parameters.
In future studies, we will increase the frequency, duration, and intensity of tones delivered on the TISF night. First, we will define sleep fragmentation as waking at least every 8 min after sleep onset instead of every 10 min, striving to increase the frequency of awakenings to ensure a significant difference in number of awakenings between the undisturbed and the TISF nights. While 8 min is still less intrusive than the frequency used by other researchers, it is likely to be sufficient to produce a measurable effect. In addition, after the first 8 min of scored sleep, we will begin to deliver warbled tones at a frequency of 1,000 Hz and 80 dB hearing level (dB HL) but at least 20 dB greater than the behavioral threshold obtained during wake. Eighty dB HL is equivalent to 80 dB sound pressure level (dB SPL). We will present the tones three times for 5 s each with silent intervals of 1 s between the tones. Each set of three tones (total of 15À20 s) will be counted as a single presentation. We will not, however, exceed, the U.S. Department of Labor Occupational Noise Exposure Standard for maximum allowable sound exposure time and intensity (American Academy of Audiology, 2003).
We will continue to define waking in two ways: (a) EEGscored waking and (b) behavioral observation (appropriate verbal response). In addition, based on the results of this study and other preliminary work, we will continue to conceptualize sleep fragmentation as frequent, brief (8-13 min) alternating periods of wake and sleep throughout the night rather than using wake after sleep onset (WASO). We believe that the number of awakenings is most descriptive of the sleep fragmentation and behavioral state instability seen in this population because, rather than a few lengthy (30 min or more) periods of wakefulness after sleep onset, we have instead most often observed numerous very brief alternating periods of wake and sleep. Although this preliminary study included only four participants, it has sufficiently demonstrated the feasibility of the proposed study methods in persons with mild AD with the modifications described above.
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